bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2023,
Volume and Issue:
unknown
Published: July 1, 2023
Abstract
Non-coding
RNAs
(ncRNAs)
act
as
important
modulators
of
gene
expression
and
they
have
been
confirmed
to
play
critical
roles
in
the
physiology
development
malignant
tumors.
Understanding
synergism
multiple
ncRNAs
competing
endogenous
RNA
(ceRNA)
regulation
can
provide
insights
into
mechanisms
tumors
caused
by
ncRNA
regulation.
In
this
work,
we
present
a
framework,
SCOM,
for
identifying
synergistic
competition.
We
systematically
construct
landscape
competition
across
31
tumors,
reveal
that
tend
share
hub
rather
than
interactions
involved
addition,
(i.e.
competition)
are
likely
be
drug
resistance,
contribute
distinguishing
molecular
subtypes
participate
immune
Furthermore,
SCOM
help
infer
uncover
potential
diagnostic
prognostic
biomarkers
Altogether,
framework
resulting
web-based
database
SCOMdb
(
www.comblab.cn/SCOMdb/
)
serve
useful
resource
exploring
accelerate
identification
carcinogenic
biomarkers.
Author
summary
Abundant
evidence
reveals
expression,
it
is
us
understand
hypothesize
acting
ceRNAs
crosstalk
with
each
other
form
name
hypothesis
.
To
biomarkers,
From
perspective
competition,
shown
involve
believe
proposed
design
reliable
diagnosis
treatment
Cell,
Journal Year:
2024,
Volume and Issue:
187(9), P. 2030 - 2051
Published: April 1, 2024
Over
the
past
50
years
in
field
of
immunology,
something
a
Copernican
revolution
has
happened.
For
long
time,
immunologists
were
mainly
concerned
with
what
is
termed
adaptive
immunity,
which
involves
exquisitely
specific
activities
lymphocytes.
But
other
arm
so-called
"innate
immunity,"
had
been
neglected.
To
celebrate
Cell's
50th
anniversary,
we
have
put
together
review
processes
and
components
innate
immunity
trace
seminal
contributions
leading
to
modern
state
this
field.
Innate
joined
center
interest
for
all
those
who
study
body's
defenses,
as
well
homeostasis
pathology.
We
are
now
entering
era
where
therapeutic
targeting
immune
receptors
downstream
signals
hold
substantial
promise
infectious
inflammatory
diseases
cancer.
Cancer Cell International,
Journal Year:
2024,
Volume and Issue:
24(1)
Published: July 19, 2024
Abstract
Dysregulated
gene
expression
and
imbalance
of
transcriptional
regulation
are
typical
features
cancer.
RNA
always
plays
a
key
role
in
these
processes.
Human
transcripts
contain
many
RNAs
without
long
open
reading
frames
(ORF,
>
100
aa)
that
more
than
200
bp
length.
They
usually
regarded
as
non-coding
(lncRNA)
which
play
an
important
cancer
regulation,
including
chromatin
remodeling,
translational
miRNA
sponges.
With
the
advancement
ribosome
profiling
sequencing
technologies,
increasing
research
evidence
revealed
some
ORFs
lncRNA
can
also
encode
peptides
participate
multiple
organ
tumors,
undoubtedly
opens
new
chapter
field
oncology
research.
In
this
review,
we
discuss
biological
function
current
methods
to
evaluate
their
coding
potential
functional
small
encoded
by
cancers.
Investigating
understanding
regulatory
mechanisms
may
contribute
deeper
development
targeted
anticancer
therapies.
Cell Death Discovery,
Journal Year:
2025,
Volume and Issue:
11(1)
Published: Jan. 18, 2025
A
new
type
of
nonapoptotic,
iron-dependent
cell
death
induced
by
lipid
peroxidation
is
known
as
ferroptosis.
Numerous
pathological
processes,
including
inflammation
and
cancer,
have
been
demonstrated
to
be
influenced
changes
in
the
ferroptosis-regulating
network.
Long
non-coding
RNAs
(LncRNAs)
are
a
group
functional
RNA
molecules
that
not
translated
into
proteins,
which
can
regulate
gene
expression
various
manners.
An
increasing
number
studies
shown
lncRNAs
interfere
with
progression
ferroptosis
modulating
ferroptosis-related
genes
directly
or
indirectly.
Despite
evidence
implicating
cancer
inflammation,
on
their
mechanisms
therapeutic
potential
remain
scarce.
We
investigate
lncRNA-mediated
regulation
immunity,
assessing
feasibility
challenges
targets
these
conditions.
Cancers,
Journal Year:
2022,
Volume and Issue:
15(1), P. 286 - 286
Published: Dec. 31, 2022
Exosomes
are
nanovesicles
secreted
into
biofluids
by
various
cell
types
and
have
been
implicated
in
different
physiological
pathological
processes.
Interestingly,
a
plethora
of
studies
emphasized
the
mediating
role
exosomes
bidirectional
communication
between
donor
recipient
cells.
Among
cargoes
exosomes,
long
non-coding
RNAs
(lncRNAs)
identified
as
crucial
regulators
cancer
cells
immune
tumor
microenvironment
(TME)
that
can
interfere
with
innate
adaptive
responses
to
affect
therapeutic
efficiency.
Recently,
few
major
focused
on
exosomal
lncRNA-mediated
interaction
infiltrated
TME.
Nevertheless,
dearth
pertains
regulating
lncRNAs
is
still
early
stages.
Comprehensive
mechanisms
immunity
not
well
understood.
Herein,
we
provide
an
overview
immunomodulatory
function
treatment
resistance.
In
addition,
also
summarize
potential
strategies
toward
Biomedicines,
Journal Year:
2023,
Volume and Issue:
11(9), P. 2411 - 2411
Published: Aug. 28, 2023
This
comprehensive
review
elucidates
the
intricate
roles
of
long
non-coding
RNAs
(lncRNAs)
within
colorectal
cancer
(CRC)
microenvironment,
intersecting
domains
immunity,
intercellular
communication,
and
therapeutic
potential.
lncRNAs,
which
are
significantly
involved
in
pathogenesis
CRC,
immune
evasion,
treatment
response
to
have
crucial
implications
inflammation
serve
as
promising
candidates
for
novel
strategies
biomarkers.
scrutinizes
interaction
lncRNAs
with
Consensus
Molecular
Subtypes
(CMSs)
their
complex
interplay
tumor
stroma
affecting
immunity
inflammation,
conveyance
via
extracellular
vesicles,
particularly
exosomes.
Furthermore,
we
delve
into
relationship
between
other
RNAs,
including
microRNAs
circular
mediating
cell-to-cell
communication
CRC
microenvironment.
Lastly,
propose
potential
manipulate
enhance
anti-tumor
thereby
underlining
significance
devising
innovative
interventions
CRC.
Drug Design Development and Therapy,
Journal Year:
2024,
Volume and Issue:
Volume 18, P. 1385 - 1398
Published: April 1, 2024
In
the
past
few
decades,
chemotherapy
has
been
one
of
most
effective
cancer
treatment
options.
Drug
resistance
is
currently
greatest
obstacles
to
treatment.
Even
though
drug
mechanisms
have
extensively
investigated,
they
not
fully
elucidated.
Recent
genome-wide
investigations
revealed
existence
a
substantial
quantity
long
non-coding
RNAs
(lncRNAs)
transcribed
from
human
genome,
which
actively
participate
in
numerous
biological
processes,
such
as
transcription,
splicing,
epigenetics,
cell
cycle,
differentiation,
development,
pluripotency,
immune
microenvironment.
The
abnormal
expression
lncRNA
considered
contributing
factor
resistance.
Furthermore,
may
be
influenced
by
genetic
and
epigenetic
variations,
well
individual
differences
patient
response,
attributable
polymorphisms
metabolic
enzyme
genes.
This
review
focuses
on
mechanism
lncRNAs
target
drugs
study
tumors
with
high
mortality,
aiming
establish
theoretical
foundation
for
targeted
therapy.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 29, 2025
Abstract
Long
noncoding
(lnc)
RNAs
are
emerging
as
imported
regulators
of
immunity
but
how
they
impact
the
host
response
to
infection
is
still
largely
unknown.
In
previous
screening
studies
we
identified
Mir17hg
and
D43Rik
lncRNAs
upregulated
in
mouse
bone
marrow-derived
macrophages
regardless
parasite
strain
type.
Here,
examined
during
macrophages.
Expression
these
was
transiently
increased
by
T.
gondii
,
peaking
6
hr
post
falling
background
noninfected
levels
18
hrs.
Both
were
predominantly
localized
cell
nucleus,
suggesting
roles
gene
regulation.
Using
a
lncRNA
silencing
approach
mediated
siRNA,
uncovered
evidence
that
both
involved
modulating
transcriptional
with
Type
I
II
strains
Toxoplasma
.
These
effects
most
dramatic
high
virulence
RH,
where
resulted
expression
broad
panel
immunity-related
genes.
Our
results
implicate
important
molecular
macrophage
Journal of Infection,
Journal Year:
2025,
Volume and Issue:
unknown, P. 106471 - 106471
Published: March 1, 2025
Dengue
virus
(DENV)
infection
is
a
significant
global
health
concern,
causing
severe
morbidity
and
mortality.
While
many
cases
present
as
mild
febrile
illness,
some
progress
to
life-threatening
dengue
(SD).
Early
intervention
essential
improve
outcomes,
but
current
predictive
methods
lack
specificity,
burdening
healthcare
systems
in
endemic
regions.
Circulating
long
non-coding
RNAs
(lncRNAs)
have
emerged
stable
promising
biomarkers.
This
study
explored
the
use
of
lncRNAs
markers
for
SD.
Differential
expression
qPCR
arrays
were
employed
identify
associated
with
Candidate
validated,
their
plasma
levels
measured
cohort
Vietnamese
patients
(n
=377)
healthy
controls
(n=128)
at
admission.
Machine
learning
algorithms
applied
predict
probability
SD
progression.
The
model
demonstrated
high
sensitivity
an
area
under
curve
(AUC)
0.98
(95%
CI:
0.96-1.0).
At
admission,
it
accurately
identified
17
18
who
later
died
high-risk,
compared
traditional
warning
signs,
which
flagged
only
9
these
cases.
Our
findings
suggest
that
this
panel
has
potential
SD,
could
help
reduce
burden
patient
management
countries.